What changes drug metabolism in critically ill patients?-II Serum inhibits the metabolism of midazolam in human microsomes
Open Access
- 1 January 1996
- journal article
- Published by Wiley in Anaesthesia
- Vol. 51 (1) , 11-15
- https://doi.org/10.1111/j.1365-2044.1996.tb07646.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A potentially hazardous interaction between erythromycin and midazolamClinical Pharmacology & Therapeutics, 1993
- In vitro forecasting of drugs which may interfere with the biotransformation of midazolamEuropean Journal of Clinical Pharmacology, 1991
- MIDAZOLAM AND ERYTHROMYCINBritish Journal of Anaesthesia, 1991
- The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended NomenclatureDNA and Cell Biology, 1991
- UNCONSCIOUSNESS ASSOCIATED WITH MIDAZOLAM AND ERYTHROMYCINBritish Journal of Anaesthesia, 1990
- APACHE IICritical Care Medicine, 1985
- The grading of sepsisBritish Journal of Surgery, 1983
- The Effective Dose of MidazolamAnesthesiology, 1981